Blood Pressure Fluctuations Pose Significant Risk Despite Normal Readings

A growing body of evidence suggests that average blood pressure readings may not be a reliable indicator of cardiovascular health.

Researchers have found that fluctuations in blood pressure throughout the day can pose a significant risk to heart disease, stroke, and brain injury, even when overall readings are within normal limits.

At the University of Virginia School of Medicine, scientists have pinpointed a specific group of nerve cells in the brainstem responsible for maintaining stable blood pressure. These neurons play a crucial role in regulating involuntary functions essential for life, including movement and bodily rhythms.

Studies show that even small losses of these nerve cells can disrupt blood pressure regulation, resulting in unstable readings despite normal mean values.

The discovery of damaged or missing nerve cells in people with multiple system atrophy has shed new light on a hidden brain mechanism behind blood pressure problems. This rare and fatal neurological disorder is often accompanied by severe difficulties regulating blood pressure, highlighting the critical role these cells play in maintaining stable readings.

Researchers are now exploring whether disruptions to these nerve cells may also contribute to unstable blood pressure in other medical conditions, even when standard measurements appear normal. This could have significant implications for how we understand and treat blood pressure problems, moving beyond simply focusing on lowering average levels.

The findings emphasize the importance of considering the stability of blood pressure from moment to moment, rather than just its average value. By doing so, researchers may uncover new avenues for developing treatments that can help protect against the potential consequences of unstable fluctuations in blood pressure.

These breakthroughs have been published in a leading scientific journal and were carried out by an international team of researchers with no financial interests related to the study.

The research breakthroughs were made possible by funding from the National Institutes of Health through grant HL148004.

This achievement aligns with the objectives of UVA's Paul and Diane Manning Institute of Biotechnology, which aims to advance research into complex diseases and expedite laboratory findings towards treatments for patients.

The significance of these discoveries underscores the importance of continued investment in medical research, ultimately leading to improved patient outcomes.